Mammalian target of rapamycin inhibitors rapamycin and RAD001 (everolimus) induce anti-proliferative effects in GH-secreting pituitary tumor cells in vitro
Alexander Gorshtein(Rabin Medical Center), Ilan Shimon(Centre for Advanced Study)
Cited by 78
Related Papers
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update
|The Journal of Clinical Endocrinology & Metabolism|2019|363
Consensus on diagnosis and management of Cushing's disease: a guideline update
|White Rose Research Online (University of Leeds, The University of Sheffield, University of York)|2021|351
Adiponectin, ghrelin, and leptin in cancer cachexia in breast and colon cancer patients
|Cancer|2006|184
High Glucose Variability Increases Mortality Risk in Hospitalized Patients
|The Journal of Clinical Endocrinology & Metabolism|2017|66